First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study

BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects multiple joints. It is associated with psoriasis and treated with synthetic and biologic drugs. OBJECTIVE: The objective of this study was to assess the outcomes of patients who received biologic therapy with tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Michael Ruberson Ribeiro, dos Santos, Jéssica Barreto Ribeiro, Kakehasi, Adriana Maria, Almeida, Alessandra Maciel, Pimenta, Pedro Ricardo Kömel, Alvares-Teodoro, Juliana, Acurcio, Francisco de Assis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671557/
https://www.ncbi.nlm.nih.gov/pubmed/36043662
http://dx.doi.org/10.1590/1516-3180.2021.0434.R1.22022022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671557/
https://www.ncbi.nlm.nih.gov/pubmed/36043662
http://dx.doi.org/10.1590/1516-3180.2021.0434.R1.22022022

Ejemplares similares